SCHEMBL30360607

SCHEMBL30360607

CC(C)N1CCN(c2ccc(-c3cnc4cc(-c5ccc(S(C)(=O)=O)cc5F)n(C)c4c3)cc2)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP4K1 Q92918 2/20 0.41
▸ ACVR1 Q04771 4/20 0.41
▸ FYN P06241 1/20 0.39
▸ PIK3CA P42336 2/20 0.38
▸ PIK3CD O00329 1/20 0.38
▸ PIK3CB P42338 1/20 0.38
▸ MTOR P42345 1/20 0.38
▸ PIK3CG P48736 1/20 0.38
▸ BMPR1B O00238 2/20 0.37
▸ BMPR1A P36894 2/20 0.37
▸ TGFBR1 P36897 2/20 0.37
▸ ACVRL1 P37023 2/20 0.37
▸ SLC6A9 P48067 1/20 0.36
▸ ACVR1B P36896 1/20 0.36
▸ TNIK Q9UKE5 1/20 0.36
▸ HRH3 Q9Y5N1 1/20 0.36
▸ ATM Q13315 1/20 0.36
▸ PRKDC P78527 1/20 0.36
▸ RAD52 P43351 1/20 0.36
▸ PTGS1 P23219 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26516732 1.00 MAP4K1 (0.41) MAP4K1ACVR1FYNPIK3CAPIK3CD
SCHEMBL26516557 0.88 MAP4K1 (0.47) MAP4K1ACVR1FYNPIK3CAPIK3CD
SCHEMBL30360601 0.88 MAP4K1 (0.47) MAP4K1ACVR1FYNPIK3CAPIK3CD
SCHEMBL26516742 0.87 MAP4K1 (0.40) MAP4K1ACVR1SLC6A9PRKDCRAD52
SCHEMBL30360618 0.87 PRKDC (0.37) MAP4K1ACVR1PRKDCPTGS1PTGS2
SCHEMBL26516738 0.87 PRKDC (0.37) MAP4K1ACVR1PRKDCPTGS1PTGS2
SCHEMBL26516639 0.85 ACVR1 (0.50) MAP4K1ACVR1FYNPIK3CAPIK3CD
SCHEMBL30360624 0.85 ACVR1 (0.50) MAP4K1ACVR1FYNPIK3CAPIK3CD
SCHEMBL30360625 0.82 HRH3 (0.41) MAP4K1ACVR1PIK3CAMTORHRH3
SCHEMBL26516735 0.82 HRH3 (0.41) MAP4K1ACVR1PIK3CAMTORHRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4200015-A1 SUBSTITUTED HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF TLR9 Bristol-Myers Squibb Company (US) 2023-06-28 — — EP claimed
CN-115956077-A Substituted heteroaryl compounds as TLR9 inhibitors 百时美施贵宝公司 2023-04-11 — — CN claimed
Send feedback